HomePVLA • NASDAQ
add
Palvella Therapeutics Inc
Previous close
$21.76
Day range
$21.43 - $25.87
Year range
$6.28 - $29.27
Market cap
269.30M USD
Avg Volume
91.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.37M | 208.33% |
Net income | -3.95M | -119.24% |
Net profit margin | — | — |
Earnings per share | -5.37 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 83.60M | 1,037.44% |
Total assets | 88.23M | 1,068.97% |
Total liabilities | 25.63M | 124.25% |
Total equity | 62.61M | — |
Shares outstanding | 11.02M | — |
Price to book | 3.82 | — |
Return on assets | -20.88% | — |
Return on capital | -26.68% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.95M | -119.24% |
Cash from operations | -5.39M | -122.21% |
Cash from investing | — | — |
Cash from financing | 74.78M | 1,395.70% |
Net change in cash | 69.40M | 2,597.05% |
Free cash flow | -1.39M | — |
About
Founded
2015
Website
Employees
14
